Innovative Pharmaceutical Biotech Limited (HKG:0399)
0.2050
-0.0070 (-3.30%)
Jun 13, 2025, 4:08 PM HKT
HKG:0399 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Net Income | 11.46 | 103.4 | -245.7 | 45.8 | -204.94 | -211.12 | Upgrade
|
Depreciation & Amortization | 0.19 | 0.94 | 1.88 | 2.13 | 2.31 | 1.24 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | -0.29 | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | - | 5.27 | Upgrade
|
Loss (Gain) on Equity Investments | - | - | - | - | - | -6.31 | Upgrade
|
Provision & Write-off of Bad Debts | -0.07 | -0.07 | -0.18 | -0.08 | 0.07 | 0.23 | Upgrade
|
Other Operating Activities | -22.39 | -116.84 | 225 | -70.07 | 183.85 | 179.62 | Upgrade
|
Change in Accounts Receivable | 1.33 | 1.33 | 3.27 | 6.14 | 0.21 | 5.34 | Upgrade
|
Change in Accounts Payable | -2.17 | -2.17 | -4.13 | 2.67 | -4.77 | -10.96 | Upgrade
|
Change in Other Net Operating Assets | 5.12 | 5.12 | 2.22 | 1.07 | -1.44 | 0.47 | Upgrade
|
Operating Cash Flow | -6.53 | -8.28 | -17.64 | -12.34 | -25.01 | -36.22 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | 0.01 | - | Upgrade
|
Investment in Securities | - | - | - | - | - | 50 | Upgrade
|
Other Investing Activities | - | - | - | -0 | - | -0.02 | Upgrade
|
Investing Cash Flow | - | - | - | -0 | 0.01 | 49.98 | Upgrade
|
Short-Term Debt Issued | - | 11.3 | 16.88 | 20 | 13 | 7 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 9.8 | Upgrade
|
Total Debt Issued | 6.5 | 11.3 | 16.88 | 20 | 13 | 16.8 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -25 | Upgrade
|
Long-Term Debt Repaid | - | -0.97 | -1.88 | -12.62 | -2.3 | -1.16 | Upgrade
|
Total Debt Repaid | -0.04 | -0.97 | -1.88 | -12.62 | -2.3 | -26.16 | Upgrade
|
Net Debt Issued (Repaid) | 6.46 | 10.33 | 15 | 7.38 | 10.7 | -9.36 | Upgrade
|
Other Financing Activities | -0 | -0.01 | -0.08 | -0.08 | -0.13 | -0.12 | Upgrade
|
Financing Cash Flow | 6.45 | 10.32 | 14.92 | 7.3 | 10.57 | -9.48 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.32 | -0.3 | -0.03 | 0.13 | 0.48 | 1.6 | Upgrade
|
Net Cash Flow | -0.39 | 1.74 | -2.75 | -4.91 | -13.94 | 5.88 | Upgrade
|
Free Cash Flow | -6.53 | -8.28 | -17.64 | -12.34 | -25.01 | -36.22 | Upgrade
|
Free Cash Flow Margin | -110.79% | -125.57% | -218.45% | -110.68% | -164.63% | -248.45% | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 | Upgrade
|
Cash Interest Paid | 0 | 0.01 | 0.08 | 0.08 | 0.13 | 0.12 | Upgrade
|
Levered Free Cash Flow | -128.15 | -139.59 | -156.25 | -121.96 | -139.37 | -115.74 | Upgrade
|
Unlevered Free Cash Flow | -1.37 | -3.28 | -10.02 | -3.24 | -19.98 | -23.84 | Upgrade
|
Change in Net Working Capital | -7.43 | -4.21 | -1.18 | -9.9 | 8.79 | 4.86 | Upgrade
|
Updated Dec 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.